Semantic Feature Analysis Treatment for Aphasia
Trial Summary
What is the purpose of this trial?
This randomized controlled comparative effectiveness study examines manipulation of a key component of an established and efficacious treatment for naming impairments in aphasia, along with cognitive and brain correlates of treatment success. Study participants will be randomly assigned to one of two treatment conditions comparing two different versions of Semantic Feature Analysis treatment. Their performance on standardized and study-specific measures will be used to determine which version of the treatment provides superior outcomes, and measures of automatic language processing and functional brain imaging will also be used to identify the underlying neurocognitive mechanisms associated with positive treatment response.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, it does require that you do not participate in any other speech-language treatment during the study.
What data supports the effectiveness of the Semantic Feature Analysis Treatment for Aphasia?
Research shows that Semantic Feature Analysis (SFA) treatment helps people with aphasia improve their ability to name objects, both for words they practice and some related words they don't practice. Studies also suggest that the more features patients generate during treatment, the better their naming skills improve, especially for the words they directly work on.12345
Is Semantic Feature Analysis Treatment for Aphasia safe for humans?
The research articles reviewed do not provide specific safety data for Semantic Feature Analysis Treatment for Aphasia, but they focus on its effectiveness in improving naming abilities in individuals with aphasia. There are no reported safety concerns in the studies, suggesting it is generally considered safe for use in humans.12367
What makes Semantic Feature Analysis Treatment unique for aphasia?
Semantic Feature Analysis Treatment is unique because it focuses on improving word retrieval by having patients generate and analyze semantic features (characteristics and meanings) of words, which can enhance naming abilities for both treated and related untreated words. This approach is different from other treatments as it emphasizes patient involvement in generating features and can be modified to include fewer features or combined with other strategies like working memory tasks to improve outcomes.12348
Research Team
William D Hula, Ph.D.
Principal Investigator
VA Pittsburgh Healthcare System
Patrick J Doyle, Ph.D.
Principal Investigator
VA Pittsburgh Healthcare System
Eligibility Criteria
This trial is for individuals who have aphasia due to a stroke in the left side of their brain, at least 6 months ago. They must be able to manage daily activities on their own or with help from a caregiver, and not have uncontrolled health issues like seizures. Participants should speak English as their first language and not be involved in other speech treatments during the study.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 60 hours of Semantic Feature Analysis treatment over a five-week period
Follow-up
Participants are monitored for safety and effectiveness after treatment, including language, eye-tracking, and fMRI testing
Treatment Details
Interventions
- Semantic Feature Analysis Treatment
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Pittsburgh Healthcare System
Lead Sponsor
Penn State University
Collaborator